Asia-Pacific Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Forecast to 2019

This report analyzes the Asian orthobiologics market by product, end user, and country. Based on products, the market has been segmented into bone graft substitutes, bone allografts, viscosupplementation, stem cell therapy, and bone growth factor and spinal stimulation. Based on end users, the market has been segmented into hospitals, orthopedic clinics, and other end users.

Japan is the largest contributor to the Asian orthobiologics market, basically due to the rising awareness about the benefits of orthobiologics, such as faster bone healing, reduction in the number of hospital visits, and quicker recovery. Owing to this, patients in Japan are increasingly opting for biological implants (orthobiologics) over mechanical implants.

The launch of new and advanced products is another major factor driving the growth of the Asian orthobiologics market. For instance, in February 2012, Zimmer, Inc. announced the launch of the Chondrofix Osteochondral Allograft, a product that is used in the treatment of osteochondral lesions using a single-stage process. This launch helped the company to expand its musculoskeletal products portfolio.

This report includes an in-depth market share analysis of the top companies operating in this market. These numbers are arrived at, based on key facts such as annual financial information from SEC filings; annual reports; and interviews with industry experts and key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report provides profiles of key players operating in the market. These profiles include various parameters, such as business overview, financial overview, product portfolio, business strategies, and recent developments undertaken by companies.

Some of the key players operating in this market include Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 13)
    2.1 Integrated Ecosystem of the Orthobiologics Market
           2.1.1 Top-Down Approach
           2.1.2 Bottom-Up Approach
           2.1.3 Macroindicator-Based Approach
    2.2 Assumptions

3 Executive Summary (Page No. - 19)

4 Market Overview (Page No. - 21)
    4.1 Introduction
    4.2 Asia Orthobiologics Market: Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics

5 Asia Orthobiologics Market, By Product (Page No. - 25)
    5.1 Introduction
    5.2 Asia Orthobiologics Market, By Product: Comparison With Orthopedic Devices Market
    5.3 Asia: Bone Graft Substitutes Market, By Country
    5.4 Asia: Bone Allografts Market, By Country
    5.5 Asia: Viscosupplementation Market, By Country
    5.6 Asia: Stem Cell Therapy Market, By Country
    5.7 Asia: Bone Growth Factor and Spinal Stimulation Market, By Country

6 Asia Orthobiologics Market, By End User (Page No. - 33)
    6.1 Introduction
    6.2 Asia: Hospitals Market, By Country
    6.3 Asia: Orthopedic Clinics Market, By Country
    6.4 Asia: Other End-Users Market, By Country

7 Asia Orthobiologics Market, By Country (Page No. - 38)
    7.1 Introduction
    7.2 Japan: Orthobiologics Market
           7.2.1 Japan: Orthobiologics Market, By Product
           7.2.2 Japan: Orthobiologics Market, By End User
    7.3 China: Orthobiologics Market
           7.3.1 China: Orthobiologics Market, By Product
           7.3.2 China: Orthobiologics Market, By End User
    7.4 India: Orthobiologics Market
           7.4.1 India: Orthobiologics Market, By Product
           7.4.2 India: Orthobiologics Market, By End User
    7.5 Republic of Korea: Orthobiologics Market
           7.5.1 Republic of Korea: Orthobiologics Market, By Product
           7.5.2 Republic of Korea: Orthobiologics Market, By End User

8 Asia Orthobiologics Market: Competitive Landscape (Page No. - 55)
    8.1 Orthobiologics Market: Company Share Analysis
    8.2 Company Presence in Orthobiologics Market, By Product
    8.3 Mergers & Acquisitions
    8.4 New Product Launches
    8.5 Expansions
    8.6 Agreements
    8.7 Other Developments

9 Asia Orthobiologics Market, By Company (Page No. - 61)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Biomet, Inc.
    9.2 Medtronic PLC
    9.3 Integra Life Sciences Corporation
    9.4 Stryker Corporation
    9.5 Zimmer, Inc.
    9.6 Depuy Synthes (Part of Johnson & Johnson)
    9.7 Tornier, Inc.
    9.8 Nuvasive, Inc.
    9.9 Exactech, Inc.
    9.10 Globus Medical Inc.
    9.11 Wright Medical Technology, Inc.
*Details On Overview, Financials, Product & Services, Strategy, and Developments Might Not Be Captured in Case of Unlisted Company

10 Appendix (Page No. - 96)
     10.1 Customization Options
             10.1.1 Regulatory Framework
             10.1.2 Epidemiology Data
             10.1.3 Surgeons/Physicians Perception Analysis
             10.1.4 Impact Analysis
     10.2 Related Reports
     10.3 Introducing RT: Real Time Market Intelligence
             10.3.1 RT Snapshots

List of Tables (42 Tables)

Table 1 Asia Orthobiologics Peer Market Size, 2014 (USD MN)
Table 2 Asia Orthobiologics Market: Macroindicators, By Country, 2014
Table 3 Asia Orthobiologics Market: Comparison With Parent Market, 2013 – 2019 (USD MN)
Table 4 Asia Orthobiologics Market: Drivers and Inhibitors
Table 5 Asia Orthobiologics Market, By Product, 2013 - 2019 (USD MN)
Table 6 Asia: Orthobiologics Market, By Product, 2013 - 2019 (USD MN)
Table 7 Asia Orthobiologics Market, By Product: Comparison With Parent Market, 2013–2019 (USD MN)
Table 8 Asia: Bone Graft Substitutes Market, By Country, 2013–2019 (USD MN)
Table 9 Asia: Bone Allografts Market, By Country, 2013 - 2019 (USD MN)
Table 10 Asia: Viscosupplementation Market, By Country, 2013 - 2019 (USD MN)
Table 11 Asia: Stem Cell Therapy Market, By Country, 2013 - 2019 (USD MN)
Table 12 Asia: Bone Growth Factor and Spinal Stimulation Market, By Country, 2013–2019 (USD MN)
Table 13 Asia: Orthobiologics Market Size, By End User, 2013 - 2019 (USD MN)
Table 14 Asia: Hospitals Market Size, By Country, 2013 - 2019 (USD MN)
Table 15 Asia: Orthopedic Clinics Market Size, By Country, 2013 - 2019 (USD MN)
Table 16 Asia: Other End-Users Market, By Country, 2013 - 2019 (USD MN)
Table 17 Asia: Orthobiologics Market Size, By Country, 2013 - 2019 (USD MN)
Table 18 Japan: Orthobiologics Market Size, By Product, 2013-2019 (USD MN)
Table 19 Japan: Orthobiologics Market Size, By End User, 2013 - 2019 (USD MN)
Table 20 China: Orthobiologics Market Size, By Product, 2013 - 2019 (USD MN)
Table 21 China: Orthobiologics Market Size, By End User, 2013 – 2019 (USD MN)
Table 22 India: Orthobiologics Market Size, By Product, 2013 - 2019 (USD MN)
Table 23 India: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Table 24 Republic of Korea: Orthobiologics Market Size, By Product, 2013 - 2019 (USD MN)
Table 25 Republic of Korea: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Table 26 Orthobiologics Market: Company Share Analysis, 2013 (%)
Table 27 Asia Orthobiologics Market: Mergers & Acquisitions
Table 28 Asia Orthobiologics Market: New Product Launches
Table 29 Asia Orthobiologics Market: Expansions
Table 30 Asia Orthobiologics Market: Agreements
Table 31 Asia Orthobiologics Market: Other Developments
Table 32 Biomet, Inc.: Key Financials, 2011 - 2013 (USD MN)
Table 33 Medtronic, PLC. : Key Financials, 2009 - 2013 (USD MN)
Table 34 Integra Life Sciences Corporation: Key Financials, 2010 - 2013 (USD MN)
Table 35 Stryker Corporation: Key Financials, 2009 - 2013 (USD MN)
Table 36 Zimmer, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 37 Depuy Synthes: Key Financials, 2011 - 2013 (USD MN)
Table 38 Tornier, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 39 Nuvasive, Inc.: Key Financials, 2009 – 2013 (USD MN)
Table 40 Exactech, Inc.: Key Financials, 2009 -2013 (USD MN)
Table 41 Globus Medical, Inc.: Key Financials, 2009 -2013 (USD MN)
Table 42 Wright Medical Technology, Inc.: Key Financials, 2011-2013 (USD MN)
 
 
List of Figures (63 Figures)
 
 
Figure 1 Asia Orthobiologics Market: Segmentation & Coverage
Figure 2 Orthobiologics Market: Integrated Ecosystem
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Macroindicator-Based Approach
Figure 6 Asia Orthobiologics Market Snapshot
Figure 7 Asia Orthobiologics Products Market, By Country, 2014 (USD MN)
Figure 8 Asia: Orthobiologics Market, By Product, 2013 - 2019 (USD MN)
Figure 9 Asia Orthobiologics Market, By Product: Comparison With Orthopedic Devices Market, 2013–2019 (USD MN)
Figure 10 Asia: Bone Graft Substitutes Market, By Country, 2013–2019 (USD MN)
Figure 11 Asia: Bone Allografts Market, By Country, 2013 - 2019 (USD MN)
Figure 12 Asia: Viscosupplementation Market, By Country, 2013 - 2019 (USD MN)
Figure 13 Asia: Stem Cell Therapy Market, By Country, 2013 - 2019 (USD MN)
Figure 14 Asia: Bone Growth Factor and Spinal Stimulation Market, By Country, 2013–2019 (USD MN)
Figure 15 Asia: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 16 Asia: Hospitals Market, By Country, 2013 - 2019 (USD MN)
Figure 17 Asia: Orthopedic Clinics Market, By Country, 2013 - 2019 (USD MN)
Figure 18 Asia: Other End-Users Market, By Country, 2013 - 2019 (USD MN)
Figure 19 Asia: Orthobiologics Market Growth Analysis, By Country, 2014-2019 (USD MN)
Figure 20 Japan: Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 21 Japan: Orthobiologics Market, By Product, 2013-2019 (USD MN)
Figure 22 Japan: Orthobiologics Market: Product Snapshot
Figure 23 Japan: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 24 Japan: Orthobiologics Market Share, By Type, 2014 & 2019 (%)
Figure 25 China: Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 26 China: Orthobiologics Market, By Product, 2013-2019 (USD MN)
Figure 27 China: Orthobiologics Market: Product Snapshot
Figure 28 China: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 29 China: Orthobiologics Market Share, By End User, 2014 & 2019 (%)
Figure 30 India: Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 31 India: Orthobiologics Market, By Product, 2013 - 2019 (USD MN)
Figure 32 India: Orthobiologics Market: Product Snapshot
Figure 33 India: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 34 India: Orthobiologics Market: End User Snapshot
Figure 35 Republic of Korea: Orthobiologics Market Overview, 2014 & 2019 (%)
Figure 36 Republic of Korea: Orthobiologics Market, By Product, 2013 - 2019 (USD MN)
Figure 37 Republic of Korea: Orthobiologics Market: Product Snapshot
Figure 38 Republic of Korea: Orthobiologics Market, By End User, 2013 - 2019 (USD MN)
Figure 39 Republic of Korea Orthobiologics Market: End User Snapshot
Figure 40 Orthobiologics Market: Company Share Analysis, 2013 (%)
Figure 41 Orthobiologics Market: Company Product Coverage, 2013
Figure 42 Biomet, Inc.: Revenue Mix, 2013 (%)
Figure 43 Contribution of Spine, Bone Healing, & Microfixation Segment To Company Revenue, 2011-2013 (USD MN)
Figure 44 Medtronic, PLC.  Revenue Mix, 2013 (%)
Figure 45 Contribution of Restorative Therapies Group Segment To Company Revenue, 2009-2013 (USD MN)
Figure 46 Integra Life Sciences Corporation: Revenue Mix, 2013 (%)
Figure 47 Contribution of U.S. Spine and Other Segment To Company Revenue, 2010-2013 (USD MN)
Figure 48 Stryker Corporation: Revenue Mix, 2013 (%)
Figure 49 Contribution of Neurotechnology and Spine Segment To Company Revenue, 2009-2013 (USD MN)
Figure 50 Zimmer, Inc.: Revenue Mix, 2013 (%)
Figure 51 Contribution of Surgical and Other Segment To Company Revenue, 2009-2013 (USD MN)
Figure 52 Depuy Synthes: Revenue Mix, 2013 (%)
Figure 53 Contribution of Medical Devices and Diagnostics Segment To Company Revenue, 2011-2013 (USD MN)
Figure 54 Tornier, Inc.: Revenue Mix 2013 (%)
Figure 55 Contribution of the Extremities Segment To Company Revenue, 2009-2013 (USD MN)
Figure 56 Nuvasive, Inc.: Revenue Mix 2013 (%)
Figure 57 Contribution of Biologics Segment To Company Revenue, 2009 - 2013 (USD MN)
Figure 58 Exactech, Inc.: Revenue Mix 2013 (%)
Figure 59 Contribution of Biologics & Spine Segment To Company Revenue, 2009 - 2013 (USD MN)
Figure 60 Globus Medical, Inc.: Revenue Mix 2013 (%)
Figure 61 Contribution of Disruptive Technology Segment To Company Revenue, 2009 - 2013 (USD MN)
Figure 62 Wright Medical Technology, Inc.: Revenue Mix 2013 (%)
Figure 63 Contribution of Biologics Segment To Company Revenue, 2011 - 2013 (USD MN)

The orthobiologics market has witnessed significant growth since 2012 owing to technological advancements in orthobiologics and growth in the number of osteoarthritis and osteoporosis patients in this region. Orthobiologics provide an effective alternative to mechanical bone implants, which take a relatively longer time to reposition and heal bones. Orthobiologics involve products that are derived from the patient’s own body and hence can be used easily without facing any immunological barrier. Owing to this advantage, these products help in faster bone healing.

The Asian orthobiologics market was valued at $1,181.9 million in 2014 and is expected to reach $1,651.6 million by 2019, at a CAGR of 6.9% from 2014 to 2019. This market has been segmented based on products, end users, and countries. Based on products, the market has been segmented into bone graft substitutes, stem cell therapy, bone allografts, viscosupplementation, and bone growth factor and spinal stimulation. Based on end users, the market has been segmented into hospitals, orthopedic clinics, and other end users. Based on geography, the market has been segmented into Japan, China, India, Republic of Korea, and the Rest of Asia (RoA).

The key players operating in this market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.), Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), NuVasive (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.), among others.